Literature DB >> 10794588

The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.

F Yantiri1, J K Andersen.   

Abstract

Parkinson disease (PD) involves the specific degeneration of dopaminergic neurons of the pars compacta of the substantia nigra. Although the cause of the degeneration of nigrostriatal dopaminergic neurons in PD is unknown, there is significant evidence to suggest that oxidative stress may be involved in this process. This review specifically examines the current status of evidence suggesting iron may contribute to oxidative damage associated with PD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10794588     DOI: 10.1080/713803493

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  7 in total

1.  Serum iron, vitamin B12 and folic acid levels in Parkinson's disease.

Authors:  Gulizar Madenci; Sule Bilen; Berna Arli; Mustafa Saka; Fikri Ak
Journal:  Neurochem Res       Date:  2012-02-26       Impact factor: 3.996

2.  Pharmacologic MRI (phMRI) as a tool to differentiate Parkinson's disease-related from age-related changes in basal ganglia function.

Authors:  Anders H Andersen; Peter A Hardy; Eric Forman; Greg A Gerhardt; Don M Gash; Richard C Grondin; Zhiming Zhang
Journal:  Neurobiol Aging       Date:  2014-10-16       Impact factor: 4.673

3.  Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro.

Authors:  G Jane Li; Qiuqu Zhao; Wei Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2005-06-01       Impact factor: 4.219

4.  Molecular mechanism of distorted iron regulation in the blood-CSF barrier and regional blood-brain barrier following in vivo subchronic manganese exposure.

Authors:  G Jane Li; Byung-Sun Choi; Xueqian Wang; Jie Liu; Michael P Waalkes; Wei Zheng
Journal:  Neurotoxicology       Date:  2006-03-20       Impact factor: 4.294

Review 5.  Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction.

Authors:  Emanuele Marzetti; Hazel Anne Lees; Stephanie Eva Wohlgemuth; Christiaan Leeuwenburgh
Journal:  Biofactors       Date:  2009 Jan-Feb       Impact factor: 6.113

6.  Iron accumulation during cellular senescence in human fibroblasts in vitro.

Authors:  David W Killilea; Hani Atamna; Charles Liao; Bruce N Ames
Journal:  Antioxid Redox Signal       Date:  2003-10       Impact factor: 8.401

7.  DCCP and DICP: construction and analyses of databases for copper- and iron-chelating proteins.

Authors:  Hao Wu; Yan Yang; Sheng Juan Jiang; Ling Ling Chen; Hai Xia Gao; Qing Shan Fu; Feng Li; Bin Guang Ma; Hong Yu Zhang
Journal:  Genomics Proteomics Bioinformatics       Date:  2005-02       Impact factor: 7.691

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.